V-Rel Reticuloendotheliosis Viral Oncogene Homolog (Avian) (REL) antibody
| Antigen | V-Rel Reticuloendotheliosis Viral Oncogene Homolog (Avian) (REL) |
| Synonyms | C-Rel, rel-A, Xrel2, REL |
| Clonality | Monoclonal (1E7) |
| Host |
Alternatives Mouse |
| Reactivity |
Alternatives Human, Mouse (Murine) |
| Conjugate |
Alternatives Un-conjugated |
| Application |
Alternatives ELISA, Immunofluorescence (IF), Immunohistochemistry (IHC), Western Blotting (WB) |
![]() |
2 references available |
| Catalog no. | ABIN968997 |
| Quantity | 0.1ml (Variants) |
| Price | 396.00 $ Plus shipping costs $45.00 |
| Shipping to |
|
| Availability | Will be delivered in 3 to 4 Business Days |
Additional Information
| Alternative name | c-Rel |
| Gene ID | 6606 |
| Immunogen | Purified recombinant fragment of human c-Rel expressed in E. Coli. |
| Format | Liquid |
| Isotype | IgG1 |
| Clone | 1E7 |
| Description |
The REL gene encodes c-Rel, a transcription factor that is a member of the Rel/NFKB family, which also includes RELA (MIM 164014), RELB (604758), NFKB1 (MIM 164011), and NFKB2 (MIM 164012). These proteins are related through a highly conserved N-terminal region termed the 'Rel domain,' which is responsible for DNA binding, dimerization, nuclear localization, and binding to the NFKB inhibitor. Synonyms: Rel, c-Rel |
| Molecular Weight | 78kDa |
Application Details
| Application Notes |
Western Blotting: 1/500 - 1/2000. Immunohistochemistry: 1/200 - 1/1000. Immunofluorescence: 1/200 - 1/1000. ELISA: Propose dilution 1/10000. Not yet tested in other applications. Determining optimal working dilutions by titration test. |
| Purification | Ascites |
| Buffer | Ascitic fluid containing 0.03% sodium azide. |
| Preservative | 0.03% sodium azide |
| Storage | Store at 4℃, for long term storage, store at -20℃. |
| Research Area | Cancer, Transcription Factors |
| Restrictions | For Research Use only |
Publications
| Product |
Garbati, Gilmore: "Ser484 and Ser494 in REL are the major sites of IKK phosphorylation in vitro: evidence that IKK does not directly enhance GAL4-REL transactivation." in: Gene expression, Vol. 14, Issue 4, pp. 195-205, 2008 (PubMed).
Trynka, Zhernakova, Romanos et al.: "Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling." in: Gut, Vol. 58, Issue 8, pp. 1078-83, 2009 (PubMed). |
Alternatives
Alternatives for antigen "V-Rel Reticuloendotheliosis Viral Oncogene Homolog (Avian) (REL)", type "Antibodies"




Alternatives